CD8A and melanoma: However, we also now demonstrate that EOMES and nLSD1p are enriched in dysfunctional PD-1+CD8+ T cells in immunotherapy-resistant melanoma and TNBC patients and that this complex is not present in melanoma patients capable of responding to immunotherapy.